48 algorithm-development-"Prof"-"Washington-University-in-St" Fellowship positions at Nature Careers in United States
Sort by
Refine Your Search
-
. Interest in clinical algorithm development and dexterity with biostatistical coding in R or Python is a plus. The primary goal of this aspect of the CH CARE Study is to combine serially obtained somatic and
-
opportunities in many Pediatric sub-specialties, not exclusive to Hematology and Oncology. Key Responsibilities Research Design & Execution: Develop and lead clinical informatics research projects focused
-
developing drugs for the treatment of cancer, vascular anomalies, macular degeneration and glaucoma. The group is dedicated to identifying novel targets, pursuing high throughput screening of therapeutics and
-
The Postdoctoral Fellow for the Department of Biochemistry and Molecular Biology will be responsible for contributing to the development and application of advanced proteomic technologies
-
months, carry a $75,000/year stipend, and include a $15,000 allowance to cover expenses related to independent research endeavors, training, and professional development. All Fellows will receive
-
team is seeking a highly motivated candidate with skills and understanding in antigen presentation utilizing bioinformatics tools to be applied to vaccine development utilizing viral vectors
-
. Investigation of mechanisms underlying neurodegenerative diseases, including Alzheimer’s disease, and the development of novel biomarkers using the retina-brain axis as a model. 3. Understanding the role
-
Anderson Cancer Center. Dr. Wang's laboratory conducts cutting-edge research to understand the evolution of cancer transcriptomes through DNA-RNA dynamics, aiming to uncover mechanisms of cancer initiation
-
We seek a talented and highly motivated computational postdoctoral fellow with a strong background in bioinformatics and passion in exploring the heterogeneity and evolution of tumor cells and the
-
as well as animal models (GEMs and PDX) to understand the mechanisms of drug resistance and to help early preclinical therapeutic development in many translational studies with a focus on breast and